Vinod Chandran, Ph.D.
Affiliations: | 2013 | Medical Science | University of Toronto, Toronto, ON, Canada |
Area:
Genetics, Medicine and SurgeryGoogle:
"Vinod Chandran"Parents
Sign in to add mentor| Dafna Gladman | grad student | 2013 | University of Toronto | |
| (Genetic Determinants of Psoriatic Arthritis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chandran V, Bessette L, Thorne C, et al. (2024) Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and Therapy. 11: 443-455 |
| Gladman DD, Chandran V, Rosen CF, et al. (2024) Residual Disease Activity In Canadian Patients With Psoriatic Arthritis (PsA) Treated With Advanced Therapies: Results From A Multi-Registry Analysis (UNISON-PsA). The Journal of Rheumatology |
| Koussiouris J, Looby N, Kotlyar M, et al. (2024) Classifying patients with psoriatic arthritis according to their disease activity status using serum metabolites and machine learning. Metabolomics : Official Journal of the Metabolomic Society. 20: 17 |
| Chandran V, Malkov VA, Ito KL, et al. (2023) Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. Rmd Open. 9 |
| Choksi H, Li S, Looby N, et al. (2023) Identifying Serum Metabolomic Markers Associated with Skin Disease Activity in Patients with Psoriatic Arthritis. International Journal of Molecular Sciences. 24 |
| Dand N, Stuart PE, Bowes J, et al. (2023) GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Medrxiv : the Preprint Server For Health Sciences |
| Colaco K, Lee KA, Akhtari S, et al. (2023) Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.) |
| Koussiouris J, Chandran V. (2023) Autoantibodies in psoriatic disease. Advances in Clinical Chemistry. 115: 135-174 |
| Pirouzmand N, Pereira D, Sutton M, et al. (2023) Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort. The Journal of Rheumatology |
| Eder L, Lee KA, Chandran V, et al. (2023) Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention. Arthritis & Rheumatology (Hoboken, N.J.) |